Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies

Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme

Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells

Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells

ISG12a mediates cell response to Newcastle disease viral infection

Going viral with cancer immunotherapy

Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response

γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.